Cargando…
In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity
The landscape of viral strains and lineages of SARS-CoV-2 keeps changing and is currently dominated by Delta and Omicron variants. Members of the latest Omicron variants, including BA.1, are showing a high level of immune evasion, and Omicron has become a prominent variant circulating globally. In o...
Autores principales: | Mohammad, Thahani S. Habeeb, Gupta, Yash, Reidl, Cory T., Nicolaescu, Vlad, Gula, Haley, Durvasula, Ravi, Kempaiah, Prakasha, Becker, Daniel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049026/ https://www.ncbi.nlm.nih.gov/pubmed/36982188 http://dx.doi.org/10.3390/ijms24065120 |
Ejemplares similares
-
Mycolactone: A Broad Spectrum Multitarget Antiviral Active in the Picomolar Range for COVID-19 Prevention and Cure
por: Asiedu, Seth Osei, et al.
Publicado: (2023) -
Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies
por: Kumar, Sumit, et al.
Publicado: (2021) -
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
por: Gurung, Arun Bahadur
Publicado: (2020) -
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
por: Gupta, Yash, et al.
Publicado: (2023) -
In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets
por: Ricci, Federico, et al.
Publicado: (2022)